Autoimmune Idiopathic Disorders in HCV patients: Effect of direct Antiviral Agents (DAA)
Study description
Disturbi idiopatici autoimmuni in pazienti con HCV trattati con agenti antivirali diretti (DAA) per valutarne gli effetti.
Pathology
Hepatitis C Virus HCV
Study type
Cohort - observational
Status
Active
Study start date
2018
Funder Type
COHORT STUDY
Investigator
Dr.ssa med. Benedetta TERZIROLI BERETTA-PICCOLI
Recruitment
Recruiting
For information, please contact the Foundation